Floatz logo

kn046

Advanced / Metastatic Solid Tumors

Maxinovel Pty., Ltd.monoclonal_antibodyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Advanced / Metastatic Solid Tumors cohort.

Asset / SponsorPhaseRating
Max-40279-01: /
Maxinovel Pty., Ltd.
Phase 1/2CCC
THIENO(3,2-D)PYRIMIDIN-2-AMINE, 7-(4-FLUORO-2-METHOXYPHENYL)-6-METHYL-N-(1-(4-PIPERIDINYL)-1H-PYRAZOL-4-YL)-
Maxinovel Pty., Ltd.
Phase 1/2CCC

Same molecule, other indications

kn046 is also rated in:

hepatocellular carcinomaDormant
B
Indicative ·
62 / 100
View asset →
non-small cell lung carcinomaDormant
B
Indicative ·
60 / 100
View asset →
squamous cell lung carcinomaDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →